Green Tea Claims Under FDA Scanner
By Arnab Ghosh, Gaea News NetworkWednesday, September 8, 2010
NEW YORK (GaeaTimes.com)- We all have heard about the benefits of green tea but it seems from the recent actions of FDA that some of the companies are just trying to cash in on the concept. In a recent development the US Food and Drug Administration has issued warnings to 2 leading FMCG brands that make and sell Green tea in the market not to exaggerate the health claims related with their products. Unilever is facing the wrath of FDA for claiming its Lipton Green Tea 100% Naturally Decaffeinated does reduce cholesterol of the users and cuts down the chance of cardiac ailments. The agency has also expressed its displeasure for the company touting the antioxidant properties of the product.
The letters sent to Unilever and another Green tea manufacturer the previous month are the latest warnings to food manufacturers about exaggeration of nutritional benefits of their products. FDA has embarked on a mission to improve food labeling so that the users get correct information and do not get duped by companies who are hell bent on convincing the buyers about their specific products. The companies that receive the FDA warning letter are expected to respond within a fortnight. In March this year the FDA had sent similar warnings to as many as 17 companies for exaggerating the nutritional benefits of their products.
Green Tea made by Lipton which is a subsidiary of UniLiver has come under the scanner of FDA. Both Unilever and Dr. Pepper Snapple Group based In Texas have said that they will work with FDA and will resolve the issues with their products.